Revance Therapeutics, Inc.
RVNCDelisted Feb 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479290
Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Revance Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- +23 vs. Q2 2022
- Shares held
- 67.6M
- +11.6M (+20.7%) vs. Q2 2022
- Total value
- $1.82B
- +$1.05B (+135.5%) vs. Q2 2022
- New holders
- 45
- 67 more added
- Sold out
- 22
- 40 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $425.0K |
| Q4 2024 | 174 | $249.2M |
| Q3 2024 | 201 | $429.9M |
| Q2 2024 | 173 | $209.3M |
| Q1 2024 | 188 | $409.4M |
| Q4 2023 | 193 | $636.4M |
| Q3 2023 | 187 | $893.1M |
| Q2 2023 | 215 | $2.07B |
| Q1 2023 | 217 | $2.46B |
| Q4 2022 | 193 | $1.36B |
| Q3 2022 | 182 | $1.82B |
| Q2 2022 | 161 | $774.3M |
| Q1 2022 | 156 | $1.06B |
| Q4 2021 | 151 | $864.7M |
| Q3 2021 | 159 | $1.53B |
| Q2 2021 | 161 | $1.60B |
| Q1 2021 | 149 | $1.53B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,597−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Sciencast Management LP | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |